NNVC
Price:
$1.22
Market Cap:
$21.80M
NanoViricides, Inc. operates as a nano-biopharmaceutical entity, specializing in the research, development, and market introduction of pharmaceutical solutions to combat viral infections. The company's robust product pipeline includes a Human Coronavirus Program, specifically engineered to tackle both COVID-19 and various seasonal coronaviruses. For herpes-related conditions, it offers HerpeCide in multiple forms: dermal topical and eye drops to treat ailments such as shingles, postherpetic neuralgia (PHN), chickenpox, recurrent herpes labialis, genital herpes, and ocular herpes keratitis. An intraocular injectable version of HerpeCide is also under development for viral acute retinal necros...[Read more]
Industry
Biotechnology
IPO Date
2005-10-26
Stock Exchange
AMEX
Ticker
NNVC
According to NanoViricides, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.77. This represents a change of -0.90% compared to the average of -2.80 of the last 4 quarters.
The mean historical PE Ratio of NanoViricides, Inc. over the last ten years is -3.99. The current -2.77 PE Ratio has changed 6.85% with respect to the historical average. Over the past ten years (40 quarters), NNVC's PE Ratio was at its highest in in the June 2023 quarter at -0.94. The PE Ratio was at its lowest in in the June 2016 quarter at -14.05.
Average
-3.99
Median
-2.90
Minimum
-8.60
Maximum
-1.56
Discovering the peaks and valleys of NanoViricides, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 83.50%
Maximum Annual PE Ratio = -1.56
Minimum Annual Increase = -80.67%
Minimum Annual PE Ratio = -8.60
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -2.24 | -15.57% |
| 2024 | -2.65 | 70.09% |
| 2023 | -1.56 | -41.80% |
| 2022 | -2.67 | -53.34% |
| 2021 | -5.73 | 83.50% |
| 2020 | -3.12 | 50.74% |
| 2019 | -2.07 | -37.86% |
| 2018 | -3.34 | -57.64% |
| 2017 | -7.87 | -8.48% |
| 2016 | -8.60 | -80.67% |
The current PE Ratio of NanoViricides, Inc. (NNVC) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.15
5-year avg
-2.97
10-year avg
-3.99
NanoViricides, Inc.’s PE Ratio is greater than Verrica Pharmaceuticals Inc. (-3.42), less than Jasper Therapeutics, Inc. (-0.16), greater than SAB Biotherapeutics, Inc. (-447.63), less than Generation Bio Co. (-0.57), greater than Evaxion Biotech A/S (-3.11), greater than IGC Pharma, Inc. (-4.06), less than Q32 Bio Inc. (5.36), less than MAIA Biotechnology, Inc. (-1.72), greater than AN2 Therapeutics, Inc. (-4.67), greater than Tenax Therapeutics, Inc. (-8.97),
| Company | PE Ratio | Market cap |
|---|---|---|
| -3.42 | $61.03M | |
| -0.16 | $7.44M | |
| -447.63 | $31.83M | |
| -0.57 | $35.98M | |
| -3.11 | $22.99M | |
| -4.06 | $28.03M | |
| 5.36 | $161.49M | |
| -1.72 | $79.04M | |
| -4.67 | $129.89M | |
| -8.97 | $197.43M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NanoViricides, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NanoViricides, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is NanoViricides, Inc.'s PE Ratio?
How is the PE Ratio calculated for NanoViricides, Inc. (NNVC)?
What is the highest PE Ratio for NanoViricides, Inc. (NNVC)?
What is the 3-year average PE Ratio for NanoViricides, Inc. (NNVC)?
What is the 5-year average PE Ratio for NanoViricides, Inc. (NNVC)?
How does the current PE Ratio for NanoViricides, Inc. (NNVC) compare to its historical average?